金力永磁(300748.SZ)擬開展外匯衍生品交易業務
格隆匯11月5日丨金力永磁(300748.SZ)公佈,公司於2019年11月5日召開第二屆董事會第十六次會議,審議通過了《關於開展外匯衍生品交易業務的議案》,同意公司根據經營發展的需要,使用自有資金開展總額度不超過1億美元的外匯衍生品交易業務,上述交易額度自本議案經公司股東大會審議通過之日起至公司2020年年度股東大會召開之日止可以靈活滾動使用。
公司出口業務主要採用美元、歐元等外幣進行結算,因此當匯率出現較大波動時,匯兑損益對公司的經營業績會造成較大影響。為有效規避和防範外匯市場風險,防止匯率大幅波動對公司生產經營造成不利影響,公司擬使用與國際業務收入規模相匹配的資金開展外匯衍生品交易業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.